Hilltop Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hilltop Holdings's BMY Position: Q2 2026 in Review
Hilltop Holdings reduced its Bristol-Myers Squibb (BMY) stake by 7.4% in Q2 2026, selling an estimated $108K and leaving 23,318 shares worth $1.34M. The position accounts for 0.1% of the portfolio, ranked #203.
Hilltop Holdings first reported a position in BMY in Q1 2014 and has held it in 50 quarters since. The position peaked at $2.92M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hilltop Holdings held 23,318 shares of Bristol-Myers Squibb worth $1.34M as of Q2 2026.
- Hilltop Holdings sold 1,875 Bristol-Myers Squibb shares in Q2 2026, an estimated $108K.
- Bristol-Myers Squibb made up 0.1% of Hilltop Holdings's portfolio in Q2 2026, its #203 holding.
- Hilltop Holdings first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 50 quarters since.
- Hilltop Holdings's Bristol-Myers Squibb position peaked at $2.92M in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.